Cortés, J., Guerrero-Zotano, A., Gion, M., Torres, C. A., Cruz, L. D. L., González, A. L., Ponce-Lorenzo, J. J., Untch, M., Gallardo, C. M., Verbeni, M., Pedragosa, M., Fazal-Salom, J., Todoriuk, M., García, J. M. P., Llombart-Cussac, A. (2026). Camizestrant plus ribociclib in hormone receptor–positive/HER2-negative advanced breast cancer: The phase II CADILLAC trial.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.tps1150